Scale, Science and Policy: How GLP-1s Work and Cost Rise

Ian Sample outlines how many people use GLP-1s, their diabetes origins and appetite mechanisms, trial evidence of large weight loss, Eli Lilly price rises, NHS access limits, and what studies say about stopping and required support.